Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or

Zeltiq Aesthetics (ZLTQ) NASDAQ

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]] [[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]] [[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview as of [[ item.timeDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
3-Month Performance
View Chart

Fundamentals

See More
  • Market Capitalization, $K 1,759,390
  • Shares Outstanding, K 39,630
  • Annual Sales, $ 255,420 K
  • Annual Income, $ 41,800 K
  • 36-Month Beta 1.00
  • Price/Sales 6.76
  • Price/Book 14.04

Price Performance

See More
Period Period Low Period High Performance
1-Month
32.54 +33.84%
on 11/03/16
44.31 -1.72%
on 12/02/16
+11.13 (+34.33%)
since 11/02/16
3-Month
32.07 +35.80%
on 11/02/16
44.31 -1.72%
on 12/02/16
+5.48 (+14.39%)
since 09/02/16
52-Week
18.41 +136.56%
on 02/16/16
44.31 -1.72%
on 12/02/16
+13.25 (+43.73%)
since 12/02/15

Most Recent Stories

More News
New Strong Buy Stocks for November 10th

New Strong Buy Stocks for November 10th

ZELTIQ Announces Third Quarter 2016 Financial Results

Revenue of $95.2 million, up 55% Year-over-Year; North America Account Utilization Increase of 25% Year-over-Year; Net income of $5.2 million; Adjusted EBITDA of $16.6 million or 17.4% of Revenues; Increases...

ZELTIQ Announces Third Quarter 2016 Financial Results

Revenue of $95.2 million, up 55% Year-over-Year; North America Account Utilization Increase of 25% Year-over-Year; Net income of $5.2 million; Adjusted EBITDA of $16.6 million or 17.4% of Revenues; Increases...

Medical Product Q3 Earnings on Nov 9: ICUI, EGRX & More

Let's take a look at the major Medical Product stocks slated to release their third-quarter results on Nov 9.

ZELTIQ Aesthetics, Inc. to Present at Investor Conferences in November 2016

PLEASANTON, CA--(Marketwired - November 01, 2016) - ZELTIQ® (NASDAQ: ZLTQ), a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling...

ZELTIQ Aesthetics, Inc. to Present at Investor Conferences in November 2016

PLEASANTON, CA--(Marketwired - November 01, 2016) - ZELTIQ® (NASDAQ: ZLTQ), a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling...

Research Reports Initiation on Medical Equipment Stocks -- Globus Medical, Align Technology, ZELTIQ Aesthetics, and Accuray

Ahead of today's trading session, Stock-Callers.com takes notice of these Medical Appliances and Equipment equities: Globus Medical Inc. (NYSE: GMED), Align Technology Inc. (NASDAQ: ALGN), ZELTIQ Aesthetics...

Sientra Announces Chief Financial Officer Transition

Sientra, Inc. (NASDAQ:SIEN), a medical aesthetics company, today announced that Patrick F. Williams has been appointed Chief Financial Officer, Senior Vice President, and Treasurer, effective immediately....

Zacks.com featured highlights: Capital Senior Living, Zayo Group Holdings, Paycom Software, PTC and ZELTIQ Aesthetics

Zacks.com featured highlights: Capital Senior Living, Zayo Group Holdings, Paycom Software, PTC and ZELTIQ Aesthetics

5 Toxic Stocks to Abandon or Play Short

If you are a smart investor and can precisely spot toxic stocks, you may gain by resorting to an investing strategy called short selling.

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 96% Buy with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More

Business Summary

Zeltiq Aesthetics Inc. is a medical technology company engaged in designing, development and commercialization of non-invasive procedures for the reduction of unwanted fat tissue. The Company offers CoolSculpting System and other products to the dermatologists, plastic surgeons, and aesthetic specialists...

See More

Support & Resistance

2nd Resistance Point 44.84
1st Resistance Point 44.19
Last Price 43.55
1st Support Level 43.02
2nd Support Level 42.50

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.